Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  Ä $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

The Pharmaceutical Market : Vietnam

Enquire | Email | Print

Published Date: May, 2012
Format: PDF
No of Pages: 56
 
 
Select pricing :
Change Currency: Ä EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

THE PHARMACEUTICAL MARKET: VIETNAM - REVIEW

The macroenvironment is positive for Vietnamís pharmaceutical market growth, despite concerns over IPR. Economically, the Economist Intelligence Unit projects Vietnamís GDP to be one of the smallest in the Asia Pacific region by 2017, ranked 14th. Legally, despite Vietnam remaining on the USTR Special 301 Watch List in 2011, the USA is encouraged by the governmentís attempts to improve IPR protection and its enforcement; particularly of note are recent amendments to the IP Law. Demographically, Vietnam has a large and young population, which will be the eighth largest population in the Asia Pacific region by 2017. The elderly population is rising, albeit slowly, and will remain one of the lowest proportions in the Asia Pacific region.

The Drug Administration of Vietnam (DAV) warned that drug prices could rise slightly in 2011 due to volatile raw material prices and the VND-US$ exchange rate. The Vietnam Pharmaceutical Companies Association (VNPCA) forecast higher sales prices for both imported and domestic drugs in 2011, due to higher input costs and rising world prices. To review the local pharmaceutical market and prevent large drug price increases, the DAV has announced several measures. Accordingly, the DAV will step-up the inspection of drug price quotations by pharmaceutical companies through health workgroups and will promptly publish the results. The DAV will also supervise the enforcement of state regulations on drug price management and exercise sanctions on violators.

Rising drug consumption and government investment make Vietnam an attractive pharmaceutical market. Drug consumption in per capita terms is expected to increase by around 70% from 2010 to 2014. In terms of output, Espicom estimates that pharmaceutical production has increased by a CAGR of over 25% during the period 2005 to 2010. The government has announced that improving the domestic pharmaceutical industry is the health sectorís highest priority over the next few years. A plan to develop and restructure Vietnamís pharmaceutical industry is underway, which includes boosting the production of essential drugs in order to cut prices, stabilise the market and reduce the countryís dependence on foreign pharmaceutical imports.

ENHANCED STRATEGIC INTELLIGENCE


Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
  • The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

EXECUTIVE SUMMARY.. 1
Snapshot: Strategic Espicom Analysis..2
Snapshot: Key Data Projections3
MACROENVIRONMENT  4
POLITICAL..4
ECONOMIC 5
Projections .5
LEGAL...6
Intellectual Property Rights...6
Compulsory Licensing .. 6
Bribery..6
DEMOGRAPHIC ....7
Projections .7
Latest Figures...8
Demographic Indicators...8
Births... 8
Deaths 8
Infant Deaths. 8
Life Expectancy at Birth 8
EPIDEMIOLOGY. 9
DISEASE BURDEN.9
Leading Causes of Mortality...9
DISEASE PREVALENCE.....9
Communicable Diseases...9
HIV/AIDS. 10
Non-Communicable Diseases ....10
Diabetes. 10
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS ...11
ORGANISATION..11
EXPENDITURE.....12
Projections .....12
Latest Figures.12
Government Funding13
Health Insurance .13
INFRASTRUCTURE....14
Public Infrastructure.14
Provincial DoH Infrastructure  15
WORKFORCE.16
Projections .....16
Latest Figures.16
REGULATORY AFFAIRS ..... 18
INTERNATIONAL AUTHORITY ..18
NATIONAL AUTHORITY & REGULATION...18
GOOD MANUFACTURING PRACTICE...18
MARKETING REGISTRATION.....18
Labelling...19
ADVERTISING19
PRICING & REIMBURSEMENT. 20
PRICING .. 20
Drug Prices Rises in 2011.20
Imported Drugs ...20
Drug Pricing Decree.....20
Cuts in Tax & Import Duties ..21
REIMBURSEMENT ....21
DISTRIBUTION CHANNELS..... 22
DRUG WHOLESALING... 22
Leading Wholesalers.22
DKSH Vietnam ..22
Mega Lifesciences..22
Saigon Pharmaceutical .....22
Vien Dong Pharmaceutical.....22
Zuellig Pharma..23
DRUG RETAILING..... 23
Regulatory Developments ...23
GPP Standards..23
Leading Pharmacy Chains ....23
IC Pharmacy.23
My Chau .23
MARKET ANALYSIS 24
SIZE.....24
Projections .....24
Historical Figures.25
Latest Figures.26
PRODUCT DEVELOPMENT..26
MANUFACTURING....26
Domestic Manufacturers 28
Multinational Manufacturers.....28
Vietnam-Singapore Industrial Park.28
TRADE ..... 29
Exports .....29
Imports.....31
Parallel Imports34
Balance of Trade ..35
COMPETITION.. 36
TRADE ASSOCIATIONS . 36
PharmaGroup ...36
VNPCA ....37
TRADE FAIR .. 38
7th PHARMED & HEALTHCARE VIETNAM 2012 38
COMPANY INTELLIGENCE.. 38
Domestic Manufacturers 38
Ampharco....38
Bao Long Medicine Group38
Cuu Long Pharmaceutical.38
Danapha Pharmaceutical .38
DHG Pharmaceutical....39
Domesco39
Glomed Pharmaceutical ...39
Ha Tay Pharmaceutical39
IC Asia Pharmaceutical39
Imexpharm..40
Khanh Hoa Pharmaceutical....40
Medipharco-Tenamyd Central Pharmaceutical40
Mediplantex National Pharmaceutical ..40
Mekophar ....40
OPC Pharmaceutical ....40
OPV Pharmaceutical ....40
Pharbaco Central Pharmaceutical..... 41
Saigon Pharmaceutical ..... 41
Saokim Pharmaceutical .... 41
Savi Pharmaceutical..... 41
Traphaco  41
Vien Dong Pharmaceutical .... 41
Vietnam Pharmaceutical Corporation (Vinapharm).... 41
Multinational Manufacturers.....42
Fresenius Kabi...42
Pharma Industries..42
Sanofi42
OTC PHARMACEUTICALS.. 43
MARKET...43
COMPETITION.....43
Company Intelligence.....43
Dong Do Pharmaceutical..43
Sohaco Group....43
TC Pharmaceutical..43
GENERIC PHARMACEUTICALS .....44
MARKET.. 44
COMPETITION.... 44
Company Intelligence.....44
Stada Vietnam ..44
BIOLOGICS & BIOSIMILARS ... 45
RESEARCH & DEVELOPMENT .. 45
Institute of Microbiology and Biotechnology...45
Stem Cell Bank .45
COMPETITION.... 45
Company Intelligence.....45
Mebiphar.....45
Nanogen Biopharmaceutical.45
Vabiotech.....45
Competitive Strategies ...46
CONCLUSIONS: OPPORTUNITIES & CHALLENGES ... 47
Strategic Espicom Analysis.47
MACROENVIRONMENT....47
EPIDEMIOLOGY....47
HEALTHCARE..48
REGULATORY AFFAIRS.....48
PRICING & REIMBURSEMENT49
DISTRIBUTION CHANNELS ....49
MARKET....49
COMPETITION 50
OTC PHARMACEUTICALS.50
GENERIC PHARMACEUTICALS.....50
BIOLOGICS & BIOSIMILARS...50
Radar Analysis....52
SWOT Analysis....52
DIRECTORY  53
GOVERNMENT ORGANISATIONS...53
PHARMACEUTICAL PRODUCERS ...53
Domestic Manufacturers 53
Multinational Manufacturers.....53
PHARMACEUTICAL WHOLESALERS ... 54
PHARMACY CHAINS 54
TRADE ASSOCIATIONS . 54
METHODOLOGY & SOURCES.. 56

List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012.....2
Key Data Projections, 2012-2017 ..3
Political Landscape, 2012..4
Regional Ranking of Projected Economies, 2017..5
Projected Economy, 2012-2017 .....5
Regional Ranking of Projected Demographics, 2017..7
Projected Demographics, 2012-2017..7
Population by Region, 2004-2008 (000s) 8
Communicable Diseases, 20079
Non-Communicable Diseases, 2007.10
Regional Ranking of Projected Expenditure, 2017....12
Projected Health Expenditure, 2012-2017.....12
Health Expenditure by Type, 2004-2009 (VND Millions)13
State Healthcare Expenditure, 2006-2012 (VND Billions).....13
Public Healthcare Establishments by Type, 2002-2008..14
Public Healthcare Beds by Type, 2002-2008 (000s)..14
Provincial DoH Establishments by Type & Region, 2008.15
Provincial DoH Beds by Type & Region, 200815
Regional Ranking of Projected Physicians, 2017.16
Projected Physicians, 2012-2017.16
Public Healthcare Personnel by Type, 2002-2008 (000s)17
Provincial DoH Personnel by Type & Region, 2008...17
Regional Ranking of Projected Pharmaceutical Markets, 2017..24
Projected Pharmaceutical Market at Retail Prices, 2012-2017....25
Historical Pharmaceutical Market at Retail Prices, 1995-2011....25
Pharmaceutical Production by Sector, 2005-2010 (VND Billions).....27
Pharmaceutical Exports by Category, 1995-2010 (US$000s)29
Pharmaceutical Imports by Category, 1995-2010 (US$000s).....31
Imports of Raw Materials by Country/Region, 2010 (US$000s).33
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s).....33
Imports of Medicaments by Country/Region, 2010 (US$000s) ..34
Pharmaceutical Balance of Trade, 1995-2010 (US$000s).....35
VNPCA Members, 2011....37
Espicom Analysis of the Pharmaceutical Market, 2012...51
SWOT Analysis of the Pharmaceutical Market, 2012.52


Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 165986, price: INR 65668, Espicom Business Intelligence

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online